Ben Markman Selected Research

Bevacizumab (Avastin)

5/2012	Application of monoclonal antibodies as cancer therapy in solid tumors.
8/2010	Monoclonal antibodies in solid tumours.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ben Markman Research Topics

Disease

25	Neoplasms (Cancer) 03/2024 - 10/2008
5	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 11/2009
5	Disease Progression 01/2023 - 01/2020
2	Nausea 08/2020 - 01/2018
2	Melanoma (Melanoma, Malignant) 01/2020 - 05/2012
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 12/2018
2	Lung Neoplasms (Lung Cancer) 05/2012 - 08/2010
1	Hepatitis 12/2021
1	Adrenocortical Carcinoma 12/2021
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Vomiting 08/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020
1	Papillary Thyroid Cancer 01/2020
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2020
1	Carcinoid Tumor (Carcinoid) 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Colitis 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Thyroid Neoplasms (Thyroid Cancer) 01/2020
1	Endometrial Neoplasms (Endometrial Cancer) 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 12/2018
1	Triple Negative Breast Neoplasms 12/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Dehydration (Water Stress) 01/2018
1	Anorexia 01/2018
1	Abdominal Pain (Pain, Abdominal) 01/2018
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018
1	Fatigue 01/2018
1	Heart Failure 01/2018
1	Pulmonary Hypertension 01/2018
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 11/2009
1	Breast Neoplasms (Breast Cancer) 10/2008

Drug/Important Bio-Agent (IBA)

5	NivolumabIBA 01/2022 - 01/2020
5	IpilimumabIBA 12/2021 - 05/2012
4	ErbB Receptors (EGF Receptor)IBA 10/2011 - 11/2009
3	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2020
3	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2020
3	Panitumumab (Vectibix)FDA Link 05/2012 - 11/2009
3	Trastuzumab (Herceptin)FDA Link 05/2012 - 10/2008
3	Cetuximab (Erbitux)FDA Link 05/2012 - 11/2009
2	Proteins (Proteins, Gene)FDA Link 03/2024 - 11/2021
2	Programmed Cell Death 1 ReceptorIBA 03/2024 - 11/2021
2	Mechanistic Target of Rapamycin Complex 1IBA 05/2014 - 05/2011
2	Bevacizumab (Avastin)FDA Link 05/2012 - 08/2010
2	catumaxomabIBA 05/2012 - 08/2010
2	Monoclonal AntibodiesIBA 05/2012 - 10/2011
1	regorafenibIBA 11/2023
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2023
1	Gefitinib (Iressa)FDA Link 01/2023
1	VemurafenibIBA 01/2023
1	durvalumabIBA 01/2023
1	AntibodiesIBA 01/2023
1	MesothelinIBA 01/2022
1	Immunoconjugates (Immunoconjugate)IBA 01/2022
1	B7-H1 AntigenIBA 11/2021
1	Docetaxel (Taxotere)FDA Link 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 08/2020
1	tislelizumabIBA 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	Codon (Codons)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	N- (4- ((3- (2- amino- 4- pyrimidinyl)- 2- pyridinyl)oxy)phenyl)- 4- (4- methyl- 2- thienyl)- 1- phthalazinamineIBA 12/2018
1	PlatinumIBA 12/2018
1	taxaneIBA 12/2018
1	Cisplatin (Platino)FDA LinkGeneric 12/2018
1	Etoposide (VP 16)FDA LinkGeneric 12/2018
1	Aurora KinasesIBA 12/2018
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2018
1	LigandsIBA 01/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2018
1	Pemetrexed (MTA)FDA Link 01/2018
1	Carboplatin (JM8)FDA LinkGeneric 01/2018
1	demcizumabIBA 01/2018
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018
1	napabucasinIBA 01/2018
1	Hyaluronic Acid (Hyaluronan)IBA 01/2018
1	Mechanistic Target of Rapamycin Complex 2IBA 05/2014
1	XL765IBA 05/2014
1	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2014
1	Drug CombinationsIBA 01/2013
1	Denosumab FDA Link 05/2012
1	Cytotoxins (Cytolysins)IBA 05/2012
1	imgatuzumabIBA 10/2011
1	MTOR InhibitorsIBA 11/2010
1	dactolisibIBA 10/2008
1	Ribosomal Proteins (Ribosomal Protein)IBA 10/2008
1	Everolimus FDA Link 10/2008
1	TensinsIBA 10/2008
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2008

Therapy/Procedure

15	Therapeutics 03/2024 - 10/2008
7	Immunotherapy 12/2021 - 01/2016
5	Drug Therapy (Chemotherapy) 08/2020 - 01/2018
1	Chemoradiotherapy 01/2023
1	Radiotherapy 01/2021
1	Castration 12/2018